Suchergebnisse - "Thuluvath, Paul J."

PubPharm (426)

1

Older Patients With Acute on Chronic Liver Failure Have a Higher Waitlist Mortality, but Acceptable Post Liver Transplantation Survival When Compared to Younger Patients

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Alukal, J. | Li, F. | Thuluvath, P.

2

Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Mózes, F. | Lee, J. | Vali, Y. | +41

3

COVID-related Vanishing Bile Duct Syndrome (VBDS)

enthalten in: Journal of clinical and experimental hepatology | 2024

von Russe-Russe, J. | Liu, L. | Thuluvath, P.

4

The Lower Survival in Patients With Alcoholism and Hepatitis C Continues in the DAA Era

enthalten in: Transplantation | 2024

von Thuluvath, P. | Amjad, W. | Russe-Russe, J. | +1

5

The Role of Endoscopy for Primary and Secondary Prophylaxis of Variceal Bleeding

enthalten in: Gastrointestinal endoscopy clinics of North America | 2024

von Ma, A. | Thuluvath, P.

6

Potential augmentation of terlipressin antidiuretic effects by gabapentinoids

enthalten in: Journal of hepatology | 2024

von Markham, P. | Bajaj, J. | Thuluvath, P. | +2

7

Hepatorenal Syndrome-Acute Kidney Injury Definition Needs a Minimum Threshold for Serum Creatinine

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Thuluvath, P.

CommentOn: Clin Gastroenterol Hepatol. 2022 Dec;20(12):2707-2716. - PMID 36075500

8

Open-label, clinical trial extension : Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Mayo, M. | Vierling, J. | Bowlus, C. | +20

9

Open‐label, clinical trial extension : Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Mayo, M. | Vierling, J. | Bowlus, C. | +20

10

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Mayo, M. | Vierling, J. | Bowlus, C. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[43]